^
Association details:
Biomarker:PAEP elevation
Cancer:Non Small Cell Lung Cancer
Drug Class:Immunotherapy
Direction:Resistant
Evidence:
Evidence Level:
Resistant: C3 – Early Trials
Title:

EP16.01-019 - The Role of the Pregnancy Associated Protein Glycodelin and Its Influence on the Immune System in Non-small-Cell Lung Cancer

Published date:
07/12/2022
Excerpt:
In patients, high serum concentrations of glycodelin were associated with a decreased progression-free survival (p < 0.001) of female patients receiving an anti-PD-1 / PD-L1 therapy...In conclusion, we demonstrate that glycodelin is a protein with a high potential of being a novel target in immuno-oncology especially for NSCLC patients.